Immunology

  1. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma

    1. Jiejie Geng
    2. Liang Chen
    3. Yufeng Yuan
    4. Ke Wang
    5. Youchun Wang
    6. Chuan Qin
    7. Guizhen Wu
    8. Ruo Chen
    9. Zheng Zhang
    10. Ding Wei
    11. Peng Du
    12. Jun Zhang
    13. Peng Lin
    14. Kui Zhang
    15. Yongqiang Deng
    16. Ke Xu
    17. Jiangning Liu
    18. Xiuxuan Sun
    19. Ting Guo
    20. Xu Yang
    21. Jiao Wu
    22. Jianli Jiang
    23. Ling Li
    24. Kun Zhang
    25. Zhe Wang
    26. Jing Zhang
    27. Qingguo Yan
    28. Hua Zhu
    29. Zhaohui Zheng
    30. Jinlin Miao
    31. Xianghui Fu
    32. Fengfan Yang
    33. Xiaochun Chen
    34. Hao Tang
    35. Yang Zhang
    36. Ying Shi
    37. Yumeng Zhu
    38. Zhuo Pei
    39. Fei Huo
    40. Xue Liang
    41. Yatao Wang
    42. Qingyi Wang
    43. Wen Xie
    44. Yirong Li
    45. Mingyan Shi
    46. Huijie Bian
    47. Ping Zhu
    48. Zhi-Nan Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

    1. Amarendra Pegu
    2. Sarah O’Connell
    3. Stephen D Schmidt
    4. Sijy O’Dell
    5. Chloe A. Talana
    6. Lilin Lai
    7. Jim Albert
    8. Evan Anderson
    9. Hamilton Bennett
    10. Kizzmekia S. Corbett
    11. Britta Flach
    12. Lisa Jackson
    13. Brett Leav
    14. Julie E. Ledgerwood
    15. Catherine J. Luke
    16. Mat Makowski
    17. Paul C. Roberts
    18. Mario Roederer
    19. Paulina A. Rebolledo
    20. Christina A. Rostad
    21. Nadine G. Rouphael
    22. Wei Shi
    23. Lingshu Wang
    24. Alicia T. Widge
    25. Eun Sung Yang
    26. the mRNA-1273 Study Group
    27. John H. Beigel
    28. Barney S. Graham
    29. John R Mascola
    30. Mehul S. Suthar
    31. Adrian McDermott
    32. Nicole A. Doria-Rose

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies

    1. Tal Noy-Porat
    2. Avishay Edri
    3. Ron Alcalay
    4. Efi Makdasi
    5. David Gur
    6. Moshe Aftalion
    7. Yentl Evgy
    8. Adi Beth-Din
    9. Yinon Levy
    10. Eyal Epstein
    11. Olga Radinsky
    12. Ayelet Zauberman
    13. Shirley Lazar
    14. Shmuel Yitzhaki
    15. Hadar Marcus
    16. Angel Porgador
    17. Ronit Rosenfeld
    18. Ohad Mazor

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates

    1. Stéphane Pillet
    2. Prabhu S. Arunachalam
    3. Guadalupe Andreani
    4. Nadia Golden
    5. Jane Fontenot
    6. Pyone Pyone Aye
    7. Katharina Röltgen
    8. Gabrielle Lehmicke
    9. Philipe Gobeil
    10. Charlotte Dubé
    11. Sonia Trépanier
    12. Nathalie Charland
    13. Marc-André D’Aoust
    14. Kasi Russell-Lodrigue
    15. Christopher Monjure
    16. Robert V. Blair
    17. Scott D. Boyd
    18. Rudolf P. Bohm
    19. Jay Rappaport
    20. François Villinger
    21. Nathalie Landry
    22. Bali Pulendran
    23. Brian J. Ward

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection

    1. Luisa Cervantes-Barragan
    2. Abigail Vanderheiden
    3. Charlotte J. Royer
    4. Meredith E. Davis-Gardner
    5. Philipp Ralfs
    6. Tatiana Chirkova
    7. Larry J. Anderson
    8. Arash Grakoui
    9. Mehul S. Suthar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Optimised non-coding regions of mRNA SARS-CoV-2 vaccine CV2CoV improves homogeneous and heterogenous neutralising antibody responses

    1. Nicole Roth
    2. Jacob Schön
    3. Donata Hoffmann
    4. Moritz Thran
    5. Andreas Thess
    6. Stefan O. Mueller
    7. Benjamin Petsch
    8. Susanne Rauch

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2

    1. Shiyu Sun
    2. Yueqi Cai
    3. Tian-Zhang Song
    4. Yang Pu
    5. Lin Cheng
    6. Hairong Xu
    7. Jing Sun
    8. Chaoyang Meng
    9. Yifan Lin
    10. Haibin Huang
    11. Fang Zhao
    12. Silin Zhang
    13. Yu Gao
    14. Jian-Bao Han
    15. Xiao-Li Feng
    16. Dan-Dan Yu
    17. Yalan Zhu
    18. Pu Gao
    19. Haidong Tang
    20. Jincun Zhao
    21. Zheng Zhang
    22. Jiaming Yang
    23. Zhenxiang Hu
    24. Yang-Xin Fu
    25. Yong-Tang Zheng
    26. Hua Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine

    1. Charles C. Reed
    2. Katherine Schultheis
    3. Viviane M. Andrade
    4. Richa Kalia
    5. Jared Tur
    6. Blake Schouest
    7. Dustin Elwood
    8. Jewell N. Walters
    9. Igor Maricic
    10. Arthur Doan
    11. Miguel Vazquez
    12. Zeena Eblimit
    13. Patrick Pezzoli
    14. Dinah Amante
    15. Maciel Porto
    16. Brandon Narvaez
    17. Megan Lok
    18. Brittany Spence
    19. Heath Bradette
    20. Heather Horn
    21. Maria Yang
    22. Joseph Fader
    23. Roi Ferrer
    24. David B. Weiner
    25. Swagata Kar
    26. J. Joseph Kim
    27. Laurent M. Humeau
    28. Stephanie J. Ramos
    29. Trevor R.F. Smith
    30. Kate E. Broderick

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status

    1. Jason Neidleman
    2. Xiaoyu Luo
    3. Matthew McGregor
    4. Guorui Xie
    5. Victoria Murray
    6. Warner C Greene
    7. Sulggi A Lee
    8. Nadia R Roan

    • Curated by eLife

      Evaluation Summary:

      This work will be of broad interest to those studying adaptive immunity to SARS-CoV-2, particularly with a focus on T cell immunology. The study confirms that mRNA vaccine-elicited T cell responses maintain recognition of peptides derived from VOC, and provides phenotypic characterisation of spike-specific T cells from both convalescent and infection-naive subjects.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #2 agreed to share their name with the authors.)

    Reviewed by eLife, ScreenIT

    5 evaluationsAppears in 2 listsLatest version Latest activity

  10. Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19

    1. Paulina Kaplonek
    2. Chuangqi Wang
    3. Yannic Bartsch
    4. Stephanie Fischinger
    5. Matthew J. Gorman
    6. Kathryn Bowman
    7. Jaewon Kang
    8. Diana Dayal
    9. Patrick Martin
    10. Radoslaw Nowak
    11. Ching-Lin Hsieh
    12. Jared Feldman
    13. Boris Julg
    14. Eric J. Nilles
    15. Elon R. Musk
    16. Anil S. Menon
    17. Eric S. Fischer
    18. Jason S. McLellan
    19. Aaron Schmidt
    20. Marcia B. Goldberg
    21. Michael Filbin
    22. Nir Hacohen
    23. Douglas A Lauffenburger
    24. Galit Alter

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 114 of 174 Next